Advertisement
Advertisement
U.S. Markets open in 2 hrs 43 mins
Advertisement
Advertisement
Advertisement
Advertisement

Cassava Sciences, Inc. (SAVA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
42.35+1.38 (+3.37%)
At close: 04:00PM EDT
42.61 +0.26 (+0.61%)
Pre-Market: 06:26AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close40.97
Open40.70
Bid0.00 x 900
Ask0.00 x 1100
Day's Range40.56 - 46.29
52 Week Range13.84 - 100.00
Volume4,263,649
Avg. Volume3,680,692
Market Cap1.695B
Beta (5Y Monthly)1.03
PE Ratio (TTM)N/A
EPS (TTM)-0.30
Earnings DateNov 08, 2022 - Nov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 13, 2012
1y Target Est72.50
  • InvestorPlace

    How High Can SAVA Stock Go Once the Controversy Clears?

    Sometimes, it’s hard to know who or what to believe. Such is the case when it comes to the ongoing U.S. Securities and Exchange Commission (SEC) probe into Cassava Sciences (NASDAQ:SAVA). As the biopharmaceutical company contends with data-manipulation allegations, traders have to figure out what to do with SAVA stock. There may be evidence that the case against Cassava will be closed soon, though — and that would be bullish for Cassava Sciences. Cassava Sciences is what I call a “ride or die” k

  • Zacks

    Cassava Sciences, Inc. (SAVA) Stock Moves -1.76%: What You Should Know

    Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $43.07, moving -1.76% from the previous trading session.

  • InvestorPlace

    Caution! It’s Not Safe to Jump on the SAVA Stock Hype Train.

    There’s been some drama surrounding Cassava Sciences (NASDAQ:SAVA) recently. First, there was a report stating that the Securities and Exchange Commission, or SEC, cleared Cassava Sciences of charges of manipulating research results. Not long afterward, however, Cassava disputed the legitimacy of that report. These twists and turns in the ongoing story make it difficult to recommend SAVA stock with confidence now. Let’s start with the basics. Cassava Sciences is a biotechnology firm with a prima

Advertisement
Advertisement